Yi Chen
Stock Analyst at HC Wainwright & Co.
(3.93)
# 594
Out of 5,147 analysts
456
Total ratings
41.75%
Success rate
13.74%
Average return
Main Sectors:
Stocks Rated by Yi Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DRTS Alpha Tau Medical | Maintains: Buy | $9 → $12 | $7.76 | +54.64% | 22 | Feb 24, 2026 | |
| BLCO Bausch + Lomb | Maintains: Buy | $17 → $20 | $18.30 | +9.29% | 21 | Feb 23, 2026 | |
| RGNX REGENXBIO | Maintains: Buy | $34 → $32 | $9.04 | +253.98% | 15 | Feb 10, 2026 | |
| BLTE Belite Bio | Reiterates: Buy | $185 | $190.30 | -2.79% | 23 | Jan 28, 2026 | |
| NPCE NeuroPace | Maintains: Buy | $18 → $19 | $14.58 | +30.32% | 2 | Jan 27, 2026 | |
| SMTI Sanara MedTech | Reiterates: Buy | $36 | $20.44 | +76.13% | 7 | Jan 26, 2026 | |
| LPCN Lipocine | Maintains: Buy | $7 → $15 | $9.96 | +50.60% | 6 | Jan 21, 2026 | |
| VRAX Virax Biolabs Group | Reiterates: Buy | $3 → $1 | $0.23 | +339.17% | 2 | Jan 9, 2026 | |
| GLSI Greenwich LifeSciences | Maintains: Buy | $39 → $50 | $27.72 | +80.38% | 9 | Dec 30, 2025 | |
| BLFS BioLife Solutions | Reiterates: Buy | $32 | $24.20 | +32.23% | 5 | Dec 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $1.5 | $0.70 | +114.59% | 8 | Dec 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2.5 → $5.5 | $1.51 | +264.24% | 2 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $21 | $8.94 | +134.90% | 30 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $39 | $31.73 | +22.91% | 3 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $1.15 | +508.70% | 3 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $9 | $2.67 | +237.08% | 11 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2.5 → $1.5 | $0.21 | +604.23% | 4 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $1.40 | +400.00% | 1 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $0.58 | +584.81% | 14 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $69 | $54.18 | +27.35% | 7 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $42 | $29.41 | +42.81% | 17 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $89 | $53.25 | +67.14% | 3 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.20 | +127.27% | 2 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $2.5 | $0.58 | +332.68% | 23 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.38 | - | 24 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.71 | +309.36% | 14 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.98 | +134.90% | 20 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $4.38 | +128.31% | 5 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.09 | +378.47% | 17 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.23 | +225.20% | 7 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $2.62 | +243.51% | 2 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $4.11 | +94.65% | 20 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $23 | $17.56 | +30.98% | 23 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $11.44 | +39.86% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $25 | $18.76 | +33.26% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.20 | +150.00% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $2.58 | +1,062.79% | 20 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.76 | - | 10 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $2.00 | +24,900.00% | 5 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $48 | $14.68 | +226.98% | 8 | Apr 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $19 | $111.71 | -82.99% | 2 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.84 | - | 2 | Apr 16, 2020 |
Alpha Tau Medical
Feb 24, 2026
Maintains: Buy
Price Target: $9 → $12
Current: $7.76
Upside: +54.64%
Bausch + Lomb
Feb 23, 2026
Maintains: Buy
Price Target: $17 → $20
Current: $18.30
Upside: +9.29%
REGENXBIO
Feb 10, 2026
Maintains: Buy
Price Target: $34 → $32
Current: $9.04
Upside: +253.98%
Belite Bio
Jan 28, 2026
Reiterates: Buy
Price Target: $185
Current: $190.30
Upside: -2.79%
NeuroPace
Jan 27, 2026
Maintains: Buy
Price Target: $18 → $19
Current: $14.58
Upside: +30.32%
Sanara MedTech
Jan 26, 2026
Reiterates: Buy
Price Target: $36
Current: $20.44
Upside: +76.13%
Lipocine
Jan 21, 2026
Maintains: Buy
Price Target: $7 → $15
Current: $9.96
Upside: +50.60%
Virax Biolabs Group
Jan 9, 2026
Reiterates: Buy
Price Target: $3 → $1
Current: $0.23
Upside: +339.17%
Greenwich LifeSciences
Dec 30, 2025
Maintains: Buy
Price Target: $39 → $50
Current: $27.72
Upside: +80.38%
BioLife Solutions
Dec 29, 2025
Reiterates: Buy
Price Target: $32
Current: $24.20
Upside: +32.23%
Dec 26, 2025
Maintains: Buy
Price Target: $4 → $1.5
Current: $0.70
Upside: +114.59%
Dec 10, 2025
Maintains: Buy
Price Target: $2.5 → $5.5
Current: $1.51
Upside: +264.24%
Dec 8, 2025
Maintains: Buy
Price Target: $19 → $21
Current: $8.94
Upside: +134.90%
Dec 5, 2025
Maintains: Buy
Price Target: $26 → $39
Current: $31.73
Upside: +22.91%
Nov 24, 2025
Maintains: Buy
Price Target: $11 → $7
Current: $1.15
Upside: +508.70%
Nov 19, 2025
Maintains: Buy
Price Target: $13 → $9
Current: $2.67
Upside: +237.08%
Nov 17, 2025
Maintains: Buy
Price Target: $2.5 → $1.5
Current: $0.21
Upside: +604.23%
Nov 17, 2025
Initiates: Buy
Price Target: $7
Current: $1.40
Upside: +400.00%
Nov 17, 2025
Maintains: Buy
Price Target: $3 → $4
Current: $0.58
Upside: +584.81%
Nov 12, 2025
Maintains: Buy
Price Target: $64 → $69
Current: $54.18
Upside: +27.35%
Nov 11, 2025
Maintains: Buy
Price Target: $36 → $42
Current: $29.41
Upside: +42.81%
Nov 7, 2025
Maintains: Buy
Price Target: $98 → $89
Current: $53.25
Upside: +67.14%
Nov 3, 2025
Reiterates: Buy
Price Target: $5
Current: $2.20
Upside: +127.27%
Oct 7, 2025
Maintains: Buy
Price Target: $2 → $2.5
Current: $0.58
Upside: +332.68%
Sep 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.38
Upside: -
Sep 23, 2025
Reiterates: Buy
Price Target: $7
Current: $1.71
Upside: +309.36%
Sep 11, 2025
Reiterates: Buy
Price Target: $7
Current: $2.98
Upside: +134.90%
Sep 4, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $4.38
Upside: +128.31%
Sep 2, 2025
Reiterates: Buy
Price Target: $10
Current: $2.09
Upside: +378.47%
Sep 2, 2025
Reiterates: Buy
Price Target: $4
Current: $1.23
Upside: +225.20%
Sep 2, 2025
Reiterates: Buy
Price Target: $9
Current: $2.62
Upside: +243.51%
Aug 12, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $4.11
Upside: +94.65%
Aug 6, 2025
Maintains: Buy
Price Target: $22 → $23
Current: $17.56
Upside: +30.98%
Jul 16, 2025
Reiterates: Buy
Price Target: $16
Current: $11.44
Upside: +39.86%
May 5, 2025
Reiterates: Neutral
Price Target: $25
Current: $18.76
Upside: +33.26%
Apr 7, 2025
Reiterates: Buy
Price Target: $3
Current: $1.20
Upside: +150.00%
Jan 2, 2025
Reiterates: Buy
Price Target: $30
Current: $2.58
Upside: +1,062.79%
Nov 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.76
Upside: -
May 17, 2024
Reiterates: Buy
Price Target: $500
Current: $2.00
Upside: +24,900.00%
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $14.68
Upside: +226.98%
Feb 17, 2021
Maintains: Buy
Price Target: $18 → $19
Current: $111.71
Upside: -82.99%
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $0.84
Upside: -